ArticleScientific reports2025
The additive effect of sarcopenia and osteoporosis on all-cause mortality: a cohort analysis in a U.S. population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on: "Effectiveness of High-Intensity Versus Low-To-Moderate-Intensity Resistance Training in Improving Muscle Strength and Bone Mineral Density in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".Geriatrics & gerontology international · 2026Article
- Residential Greenness and Risk of Coronary Artery Disease Following COVID-19: A Nationwide Cohort Study in South Korea.Journal of the American Heart Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Objectives The rising incidence of sarcopenia and osteoporosis, conditions closely linked to natural aging and frequently occurring together, may have varying impacts on prognosis. The purpose of this research is to use the NHANES database to explore how sarcopenia and osteoporosis may impact all-cause mortality and to assess whether there is an additive effect of these two conditions. Methods Individuals in this research were categorized into four groups depending on whether they had sarcopenia or osteoporosis. This study employed survival curves, Cox regression analyses, and restricted cubic splines, encompassing subgroup and sensitivity analyses, to explore the relationship between sarcopenia, osteoporosis, and all-cause mortality. Results Findings from the study revealed that participants suffering from both sarcopenia and osteoporosis exhibited the lowest survival rates. After adjusting for all potential factors, individuals diagnosed with sarcopenia alone had a 45% higher chance of experiencing all-cause mortality, while those with osteoporosis alone faced a 32% increased risk of all-cause mortality. Furthermore, individuals with both sarcopenia and osteoporosis had a 282% higher risk of all-cause mortality compared to those without either condition. The relative excess risk due to interaction (RERI) between sarcopenia and osteoporosis was 4.48 [95% CI: 1.98-8.08], the attributable proportion due to interaction (AP) was 0.66 [95% CI: 0.38-0.79], and the synergy index (S) was 4.4 [95% CI: 1.9-10.2]. Conclusions This indicates that the combination of sarcopenia and osteoporosis may have an additive effect on all-cause mortality, leading to an increased likelihood of death in individuals with both ailments. This study was to emphasize the importance of prevention over treatment for osteoporosis and sarcopenia to reduce the risk of death in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.